Big gymnasium in downtown corporate campus to be demolished
The owner of the 40,000-square-foot gym says upgrading the facility would cost tens of millions of dollars, and that the cost to maintain it is greater than the property’s value.
The owner of the 40,000-square-foot gym says upgrading the facility would cost tens of millions of dollars, and that the cost to maintain it is greater than the property’s value.
The Indy-based firm plans to accelerate marketing of its platform for finding and managing on-demand digital marketing talent as well as add employees and grow the firm’s footprint beyond the Midwest.
Contracts Smart Guided Systems LLC has announced a licensing agreement with USDA Office of Technology Transfer to commercialize the Intelligent Spray Control System. Phone: 317-222-4152; E-mail: [email protected]. Fundraising Indianapolis Professional Association to benefit from “The Current State of the Local Minority Economy,” on Oct. 26 from 6-9 p.m. at The District Tap, 3720 E. 82nd […]
Eli Lilly and Co.’s stock jumped Thursday after midstage research on an experimental diabetes drug showed significant weight loss in patients. The news took a toll on shares of rival Novo Nordisk.
The IU School of Medicine said the grant, its largest-ever National Institutes of Health award, will fund a five-year study of a form of Alzheimer’s disease that affects young people.
The Indiana Seed Fund III is an early-stage fund focused on developing startups in life sciences, health IT and agricultural biosciences.
Shares in Elanco Animal Health Inc. slipped as much as 3.3 percent Monday morning after lead managers and other banks involved in its recent initial public offering started coverage on the animal health company.
The drug industry's main trade group said drug companies are only willing to disclose the prices on their websites, not in commercials, and they'll start doing that next spring.
A former Indianapolis mayor will succeed Christel DeHaan as CEO of Christel House International, an organization that operates nine schools in four countries.
The West Lafayette biotech firm’s stock traded as low as $1.41 last fall, following multiple setbacks and restructurings. But the stock had soared to $24 Thursday morning after news that it would be acquired by Novartis.
The experimental drug eased arthritis pain in hard-to-treat patients without major safety concerns, a key step in creating a new class of medications that may one day offer an alternative to narcotics.
Maigen and Jim Rowe have filled their old home with their own family’s history.
United Way of Central Indiana is our best chance to focus resources on our community’s education, financial stability, health and other needs.
President Donald Trump is linking the drug prices Americans complain about to one of his longstanding grievances: foreign countries the president says are taking advantage of U.S. research breakthroughs.
Nearly 50 demonstrators, including Democratic City-County Council members Zach Adamson and Duke Oliver, were issued written summons Thursday for violating a city ordinance and not complying with police.
A wave of corporations in central Indiana is creating venture capital arms, pushed partly by the desire to join the technological movement.
Look at the future prospects, not the losses, says the CEO of a newly listed Chinese biotech company that’s developing anti-cancer drugs with Indianapolis-based Eli Lilly and Co.
A member of Roche’s Global Quality & Regulatory Leadership Team, Danelle Miller built its regulatory policy function from the ground up.
Overseeing Eli Lilly and Co.’s philanthropic work in the United States, Kenya and Mexico, Courtney Roberts also leads a pilot program to address barriers to diabetes care in three local neighborhoods.
Working at Eli Lilly and Co. right out of college, Christi Shaw went on to other major drug companies before returning to head a division that represents about 40 percent of Lilly’s worldwide revenue.